Latest Articles

  • Re:Cognition Health becomes first network of clinical trial sites to have achieved GCSA Accredited status

    February 21, 2023

    London and Maidenhead, United Kingdom, 21 February 2023 – Re:Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA […]

  • Historical moment for Alzheimer’s treatment Re:Cognition Health proud to deliver lecanemab clinical trial

    November 29, 2022

    Re:Cognition Health’s Brain and Mind Experts are excited and proud to be delivering “Clarity“ the global clinical trial for Lecanemab, as the result of the trial is […]

  • What a world-leading Neuroradiologist wants you to know about CTE

    November 7, 2022

    With Chronic Traumatic Encephalopathy (CTE) diagnosis rates increasing rapidly and as we become more aware of the condition, particularly being brought to the forefront with international rugby […]

  • How are smartphones affecting children?

    November 7, 2022

    Whilst smartphones are part of everyday life for the majority of adults, more and more teenagers are becoming reliant upon them for social connections, directions, games and […]

  • Re:Cognition Health is absolutely thrilled to be shortlisted as a finalist in the Personal Injury Awards 2022 for Medicolegal Provider of the Year.

    October 20, 2022

    Under the leadership of multi-award-winning CEO and Consultant Neuroradiologist Dr Emer MacSweeeney and Director of Neurological Services Dr Steve Allder, our medicolegal team provide high-quality expertise in […]

  • LaingBuisson Awards 2022

    October 12, 2022

    Re:Cognition Health is absolutely delighted to announce that our team has been shortlisted in three categories in the LaingBuisson 2022 Awards which set the standards of excellence […]

  • Is your lifestyle increasing your risk of dementia?

    September 7, 2022

     Dr Emer MacSweeney, Consultant Neuroradiologist and CEO at Re:Cognition Health spoke with Health Tech World about how our  lifestyle choices may be increasing our risk of dementia. Recent research […]

  • Amyloid and Alzheimer’s

    August 11, 2022

    Amyloid and Alzheimer’s By R. Scott Turner, PhD, MD   Recent reports of fraud in Alzheimer’s disease (AD) research have raised major concerns. Some of the figures […]

  • Emer Fox5 News

    August 11, 2022

    Dr Emer MacSweeney, CEO, Medical Director and Consultant Neuroradiologist at Re:Cognition Health appeared on Fox5 News, USA,  talking about the exciting and important opportunity provided through clinical […]

  • Dr Tom MacLaren, Consultant Psychiatrist at Re:Cognition Health shares an insight into the mental health benefits of summer

    August 8, 2022

    Dr Tom MacLaren, Consultant Psychiatrist at Re:Cognition Health shares an insight into the mental health benefits of summer:  Waking up to bird song, sunshine and warmth of […]

1 2 4 5 6 7 8 23 24

Help us make a difference in cognitive health

Sign Up Now